May Barnhard Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
1,185
-88
-7% -$18.9K 0.12% 75
2026
Q1
$277K Hold
1,273
0.13% 74
2025
Q4
$291K Sell
1,273
-1
-0.1% -$228 0.14% 73
2025
Q3
$295K Buy
1,274
+1
+0.1% +$204 0.14% 72
2025
Q2
$236K Hold
1,273
0.11% 84
2025
Q1
$267K Buy
+1,273
New +$247K 0.13% 78
2024
Q4
Sell
-1,013
Closed -$200K 83
2024
Q3
$200K Buy
+1,013
New +$189K 0.1% 82

Other funds holding ABBV

May Barnhard Investments's ABBV Position: Q2 2026 in Review

May Barnhard Investments reduced its AbbVie (ABBV) stake by 6.9% in Q2 2026, selling an estimated $18.9K and leaving 1,185 shares worth $298K. The position accounts for 0.12% of the portfolio, ranked #75.

May Barnhard Investments first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • May Barnhard Investments held 1,185 shares of AbbVie worth $298K as of Q2 2026.
  • May Barnhard Investments sold 88 AbbVie shares in Q2 2026, an estimated $18.9K.
  • AbbVie made up 0.12% of May Barnhard Investments's portfolio in Q2 2026, its #75 holding.
  • May Barnhard Investments first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on May Barnhard Investments's 13F filing for Q2 2026, filed 21 Jul 2026.